(lp0
S"Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to ... Motley Fool - Mar 9, 2017 Few biotechs have enjoyed as fun a ride as Incyte Corporation  in recent years. The stock has soared more than 700% since early 2012 thanks primarily to tremendous success for cancer drug Jakafi.Earnings Clues on Incyte Corporation , Mastercard Incorporated (MA ... - StockNewsJournal"
p1
aS"Incyte Corporation Stock Rises on Price Target Increase TheStreet.com - Mar 13, 2017 Incyte  shares were up 1.3% to $151.21 in premarket trading Monday after analysts at Credit Suisse raised the company's price target to $174 from $136.Gilead Looking To Buy Incyte? It Makes Sense - Benzinga"
p2
aS'Penn cancer center forms research partnership with Incyte pharmaceutical company The Daily Pennsylvanian - Mar 2, 2017 Incyte Corporation, a pharmaceutical company, is entering into a multi-year research partnership with the Abramson Cancer Center at Penn.'
p3
aS"Why Incyte Corporation  Shares Are Skyrocketing Simply Wall St - Mar 12, 2017 Including an 8% jump on Friday, Incyte Corporation  shares are up a staggering 110% over the past year. The Delaware-based biotech firm is experiencing a growing demand for its cancer drug Jakafi (to treat myelofibrosis and polycythemia&nbsp;...Incyte Corporation  Moves Higher on Volume Spike for March 10 - Equities.comReliable stocks in today's share market: Incyte Corporation  - The News Journal"
p4
aS'Incyte Corporation: Incyte Announces Oncology Research Alliance with the ... The Wall Street Transcript - Feb 23, 2017 BUSINESS WIRE)--Feb. 23, 2017-- Incyte Corporation  today announces a multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania.University of Pennsylvania announces cancer research alliance with Incyte - DOTmed.com'
p5
aS"Incyte: Many Strengths, Small EPS, So What's It Worth? Seeking Alpha - Feb 17, 2017 Incyte  has now reported its Q4 and full-year financial results, and provided an update on its business. Since there were not a lot of surprises therein, I'll get to them later, but as I've previously said in a Dec. 5 article titled Incyte ...Incyte Corporation - Receive News &amp; Ratings Daily - Chaffey Breeze"
p6
aS"Looking at the Tea Leaves for Incyte Corporation  The USA Commerce - 23 hours ago We have gathered the technical data on Incyte Corporation , and see some interesting trends in the stock's behavior of late."
p7
aS'Incyte  Up 26.2% Since Earnings Report: Can It Continue? Nasdaq - Mar 17, 2017 A month has gone by since the last earnings report for Incyte CorporationINCY . Shares have added about 26.2% in that time frame, outperforming the market.Incyte Corporation  Future Growth Projections From Analysts - Midway MonitorIncyte Corporation  News Impact Score At 100 - Stock Observer'
p8
aS'Incyte Corporation : Is The Stock Undervalued? Business Review - 14 hours ago Incyte Corporation  has an ERP5 rank of 10988. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.'
p9
aS'How Incyte Stock Became a Bull Market Star for Biotech Investors Yahoo Finance - Mar 10, 2017 While several stocks performed well during this period, Incyte Corporation INCY tops the list -- this bull market outperformer gained a whopping 5797.9% during this 8-year period, outperforming the Zacks-categorized Medical-Biomedical/Genetics industry ...'
p10
a.